|ORIGINAL ARTICLE – RETROSPECTIVE STUDY
|Year : 2016 | Volume
| Issue : 2 | Page : 235-240
Clinical outcome of surgical treatment of T1-2 N0 squamous cell carcinoma of oral tongue with observation for the neck: Analysis of 176 cases
Arsheed Hussain Hakeem, Sultan Ahmed Pradhan, Rajan Kannan, Jagadish Tubachi
Department of Surgical Oncology, Prince Aly Khan Hospital, Mazagaon, Mumbai, Maharashtra, India
|Date of Web Publication||17-Feb-2017|
Dr. Arsheed Hussain Hakeem
Prince Aly Khan Hospital, Nesbit Road, Mazagaon, Mumbai - 400 010, Maharashtra
Objective: To analyze various demographic, clinical, and histopathologic factors in T1-2 N0 squamous cell carcinoma (SCC) of the oral tongue to define a high-risk group for regional recurrence that will benefit from elective neck dissection. Materials and Methods: Retrospective outcome analysis of a patient cohort without palpable or ultrasound (USG) detectable nodal metastases undergoing per oral wide glossectomy for T1-2 N0 SCC of oral tongue. Patients were followed up using palpation and serial USG neck and fine-needle aspiration cytology. Results: Of the 176 patients, 69 (39%) showed recurrence during follow-up. Fifty-eight cases developed regional neck node metastases, i.e., overall regional node recurrence rate of 33%. Fifty-three (91%) with regional neck node metastases were salvaged successfully with further treatment. In 110 cases with tumor thickness more than 5 mm, 39% cases developed regional neck node metastases. This association was significant with P= 0.0402. Among 44 cases with perineural invasion, 54% developed regional neck node metastases. Similarly in 39 cases with lymphovascular invasion, 61% developed regional neck node metastases. Association of both of these parameters with the development of regional neck node metastases was significant. Conclusion: We recommend prophylactic selective neck dissection in early stage SCC of oral tongue, especially with depth of invasion more than 5 mm, perineural and lymphovascular invasion.
Keywords: Elective neck dissection, nodal metastases, squamous cell carcinoma, tongue
|How to cite this article:|
Hakeem AH, Pradhan SA, Kannan R, Tubachi J. Clinical outcome of surgical treatment of T1-2 N0 squamous cell carcinoma of oral tongue with observation for the neck: Analysis of 176 cases. Ann Maxillofac Surg 2016;6:235-40
|How to cite this URL:|
Hakeem AH, Pradhan SA, Kannan R, Tubachi J. Clinical outcome of surgical treatment of T1-2 N0 squamous cell carcinoma of oral tongue with observation for the neck: Analysis of 176 cases. Ann Maxillofac Surg [serial online] 2016 [cited 2021 Sep 24];6:235-40. Available from: https://www.amsjournal.com/text.asp?2016/6/2/235/200331
| Introduction|| |
Development of the regional neck node metastases is not only the main cause of failure but also most significant prognostic indicator of survival for the oral tongue squamous cell carcinoma (SCC). Several studies have demonstrated 13%–33% and 27%–53% of occult nodal metastases in Stage I and II SCC of oral tongue, respectively., Identification of the patients without regional node metastases who do not require elective neck treatment is the greatest challenge faced by head and neck surgeons. Electively treating such necks who actually do not have the disease and form a major group means incurring unnecessary surgery and costs. It is also associated with increasing morbidity which otherwise could have been avoided. There is still no final agreement whether the N0 neck should be electively treated. Some studies have shown neither any benefit in overall survival (OS) nor any reduction of recurrence when the clinically negative neck is electively treated with surgery.,, On the contrary, some authors have reported reduction in the regional nodal metastases and prolonged OS for cases treated with elective neck dissection.,,, The identification of factors associated with high risk of lymph node metastases may be useful for the proper selection of patients that will benefit from elective neck dissection. The aim of this study is to evaluate the demographic, clinical, and pathological factors associated with the risk of occult metastases and hence prognosis in patients with clinical T1-2 N0 SCC of the oral tongue.
| Materials and Methods|| |
A retrospective analysis of early stage SCC of the oral tongue was done from January 2003 to January 2010 in Head and Neck Unit of Prince Aly Khan Hospital, Mumbai, India. This study is limited to the patients with previously untreated, biopsy proven, limited T1-2 N0 cancer of oral tongue that underwent peroral wide excision. All cases had N0 neck on clinical palpation, ultrasound (USG) with color Doppler, and guided fine-needle aspiration (FNA). Intense follow-up rather than neck dissection was used for clinically negative neck. First, USG assessment of the neck was done 4–6 weeks after surgery and thereafter every 2 months for 1 year. All the cases were asked to follow-up immediately if they felt any swelling in the neck between the follow-up time. All the patients presenting with a palpable node were subjected to fine-needle aspiration cytology for confirmation of the disease, and definite modified neck dissection was performed. Modified neck dissection meant removing of lymph node bearing areas from Level I to V and sternocleidomastoid muscle, while preserving nonlymphatic structures such as internal jugular vein and spinal accessory nerve if not directly infiltrated. M0 status was considered when there was no evidence of distant metastases by abdominal ultrasonography, and chest X-ray was normal. Staging was based on the american joint committee on cancer (AJCCs) Manual for Staging of Cancer (2002, 6th Edition). Clinical and histopathologic factors assessed included age (<40 years vs. ≥40 years), gender, clinical T-stage (T1 vs. T2 stage), tumor cell differentiation (well vs. moderate vs. poor), depth of invasion (<5 mm vs. >5 mm), presence or absence of intrinsic muscle involvement, perineural invasion, and lymphovascular invasion. All the cases were treated with peroral wide glossectomy. In all the cases, frozen section was used to see that margins are adequately free, i.e., more than 0.5–1 cm. Same was confirmed on final paraffin histopathology. On final histopathology, tumor thickness was measured from the surface of normal mucosa to the deepest portion of the tumor invasion using an optical micrometer. Perineural and lymphovascular invasion was also determined on final histopathology. Occult node metastases were defined as development of regional neck node metastases during the follow-up without recurrence at the primary site (oral tongue). While as regional neck node metastases in patients with recurrence at the tongue also was not considered occult regional neck node metastases. OS was calculated from the date of first surgical treatment to the date of last follow-up or death from any cause. Disease-free survival (DFS) was the length of time from the date of first surgical treatment to the date of recurrence.
All statistical analyses were performed using the SPSS software for Windows (version 13.0, SPSS, Chicago, IL, USA). Variables were independently tested for their relation to presence of regional recurrence using the Chi-square and Fisher's exact tests. Univariate analysis was performed to determine prognostic factors of statistical significance. Differences were considered significant for P < 0.05 and all P values were two-tailed.
| Results|| |
A total of 176 patients with a diagnosis of T1-2 N0 SCC of oral tongue were found eligible for the study. The patients were not evenly distributed by gender (133 males, 43 females). The male-to-female ratio was 3:1 in this study. At the time of diagnosis, the median age was 50 years (range: 21–86 years). The prevalence rate of habitual tobacco/betel nut/alcohol intake was documented in 108 patients, i.e., 61.37%. Premalignant lesions in the form of leukoplakia, erythroplakia, and oral submucous fibrosis were seen in 34 (19.31%) cases. Of the 108 cases with habit of tobacco/betel nut/alcohol intake, premalignancy was seen in 22 cases (20.37%). Of the 68 cases without habits, premalignancy was seen in 12 cases (17.64%) showing no statistically significant association. The median follow-up time was 56 months (standard error, 1.50; 95% confidence interval). Of the 176 patients, 69 (39%) showed recurrence during follow-up. Fifty-eight cases developed regional neck node metastases, i.e., overall regional neck node recurrence rate of 33%. Another five (3%) cases had recurrence both at the primary site and regional neck nodes and remaining six (3%) cases developed recurrent lesion in the primary site only [Table 1]. In 62 of the 69 (90%), recurrences were seen in the 1st year of the follow-up with median time to recurrence of 5 months [Table 2]. Sixty-two (90%) of the 69 recurrences could be salvaged with further treatment. In cases with only regional neck node recurrence, 53 (91%) could be salvaged. All the patients with local recurrence could be salvaged. Of the seven cases which were not amenable to salvage, five cases had unresectable regional neck node recurrence, and two cases had unresectable recurrence both at the primary site and neck. Surgery as single modality was used for ten cases, surgery with adjuvant radiotherapy in forty cases, and surgery with adjuvant chemoradiation was used in rest 12 cases for salvage. Fourteen patients developed second recurrence, of which only one could be salvaged, this patient had both first and second nodal recurrence. Rest of the thirteen could not be salvaged because of unresectable regional nodal metastases in six cases and unresectable recurrence at the primary site and regional neck nodes in seven cases. Four cases of these 13 also had distant metastases. No case of second primary cancer was found in this study group. Three patients in this group developed contralateral neck nodes. As of January 2011, 156 patients (89%) were alive without disease, whereas 15 patients (8%) were dead as a result of malignant disease, two patients (1%) were alive with disease, and three patients (2%) died from unrelated causes [Table 3]. Five-year OS and DFS for the whole cohort of patients were 90% and 61%, respectively [Figure 1] and [Figure 2]. Various clinical and pathological factors were analyzed and correlated with the development of regional node metastases. Histopathological factors such as depth of infiltration, perineural invasion, and lymphovascular invasion of the primary tumor showed statistically significant correlation to the regional neck node recurrence. In the group of 110 cases with tumor thickness more than 5 mm, 39% cases developed regional neck node metastases. On the contrary, when the tumor thickness was ≤5 mm only 23% cases had neck node metastases. This association was statistically significant with P= 0.0402 [Table 4]. Among 44 cases with perineural invasion, 54% developed regional neck node metastases. On the contrary, in 132 cases without perineural invasion only 26% developed regional neck node metastases. This association was also significant with P = 0.0009 [Table 4]. Similarly, in 39 cases with lymphovascular invasion, 61% developed metastatic regional neck nodes. On the other hand, in 137 cases without lymphovascular invasion, only 25% cases had regional neck node metastases on follow-up. This association was also significant with P = 0.0001 [Table 4]. However, regional neck node metastases did not statistically correlate with age, gender, tobacco chewing and alcohol intake, location of primary tumor, T-stage, degree of differentiation, tumor type, and mode of invasion.
|Table 2: Recurrence according to the duration from the date of primary resection|
Click here to view
|Figure 1: Kaplan–Meier curve showing overall survival at last follow-up excluding other deaths|
Click here to view
|Figure 2: Kaplan–Meier curve showing overall survival at last follow-up including other deaths|
Click here to view
|Table 4: Univariate analysis for different clinicopathologic variables with the development of neck nodes|
Click here to view
| Discussion|| |
Although elective treatment of the N0 neck may result in better regional neck control of the tumor, this routine policy subjects a significant proportion of patients to an unnecessary surgery and attendant morbidity. However, when an N0 neck with actual occult metastases is not included in the management plan, the implications are poor treatment outcome with increased morbidity and mortality rates. To address this controversial issue, we analyzed the outcomes of T1-2 N0 SCC of the oral tongue with special reference to the potential effect of the observation rather than elective neck treatment. The neck is the most common site of recurrence for early Stage I and Stage II tongue SCC. The incidence of occult disease in the lymph nodes after initial treatment ranges from 13% to 33% and 27%–53% in Stage I and II, respectively., 3, ,,,, The rate of occult metastases in regional neck nodes in our study is 33%. Therefore, strengthening the fact that clinical palpation is grossly inadequate for evaluation of N0 neck in oral SCC.,, Moreover, USG was not able to pick the metastases in this 33% clinically N0 necks in our study. This is in accordance with the other studies where available radiological investigative tools have shown some improvements in the detection of neck metastases, but sensitivity ranged between 70% and 80%.,,,, Haberal et al. found USG findings correlated more with the pathological findings than palpation, but computed tomography (CT) gave most effective and reliable results when combined with USG in neck staging. Fluorodeoxyglucose-positron emission tomography (FDG-PET) is another useful tool for evaluation of the neck because it accurately detects metastatic lymph nodes >10 mm and has fewer false positive cases than CT scan. The high specificity of FDG-PET for lymph nodes may play an important role in avoiding unnecessary neck dissection. Yonn et al. compared the diagnostic value of USG, CT, magnetic resonance imaging (MRI), and PET/CT for preoperative detection of metastases from SCC of head and neck region and showed no statistically significant difference among them. The combination of CT, MR, USG, and PET/CT improved sensitivity (86.5%), without loss of specificity (99.4%) and accuracy (97.0%) although the difference failed to reach the statistical significance. In our study, median time to recurrence was 5 months and 90% recurrences were seen in the first 12 months of the follow-up. Similarly, Yuen et al. also reported that 90% of the regional neck node recurrence occurred in the early postoperative period, within 20 months. We analyzed various clinical and pathologic parameters and correlated them with the development of regional neck nodes. Recurrence in the neck was chosen because development of regional neck nodes is not only the most common form of failure but also most important prognostic factor. The first parameter studied was the age at presentation. There are conflicting reports in literature, some studies have shown that SCC of the tongue is aggressive in the younger age group with higher local and regional recurrence. Friedlander et al. reported 44% local and regional neck node failure in case of younger patients as compared to only 22% failure in older patients with significant P < 0.05 without translation into the survival difference. On the contrary, Davidson et al. showed increased disease-specific mortality with increasing age in patients with cancer of oral tongue. In our study, although 42% of the cases with age <40 years developed regional metastatic nodes as compared to only 29% cases with age >40 years, but the association was not statistically significant (P = 0.13) [Table 4]. Neither could our data be translated into significant survival difference between the two groups. In accordance with our study, Pitman et al. and Lim and Choi could not find any significant difference in the outcomes of treatment for SCC oral tongue in the young (<40 years) and older patients (>40 years)., Several studies have focused on the correlation of depth of invasion with the occurrence of the regional neck node metastases. Nonetheless, the criteria for elective neck dissection in terms of tumor depth are still inconclusive. Fukano et al. suggested a discerning point at 5 mm depth of invasion at which cervical metastasis is probable and recommended elective neck treatment for tumors exceeding 5 mm invasion. O'Brient et al. suggested tumor depth as a significant, objectively measurable prognostic factor in early-stage oral cancer. They showed that prognosis changed significantly at a cutoff of 4 mm depth of invasion. Sparano et al. also reported that only tumors with >4 mm were associated with occult neck metastases. However, in tumors >4 mm invasion, the rate without neck metastasis was approximately 59%, forming major subgroup. In our study, only 23% of cases with depth of invasion <5 mm developed neck nodes, while 39% cases with >5 mm depth of invasion developed metastatic neck nodes. This association with cutoff of 5 mm was statistically significant with P = 0.0402 confirming the finding that depth of invasion is an important prognostic indicator of occult regional neck node metastases [Table 4]. Sparano et al. also reported that the presence of perineural invasion and lymphovascular invasion significantly correlated to occult regional neck node metastasis. Our results are in complete agreement with the findings of this study. In our study, 54% cases with perineural invasion developed metastatic neck nodes, while only 25% cases without perineural invasion had a recurrence in regional neck nodes. This correlation was significant with P = 0.0009. Moreover, 61% cases with lymphovascular invasion developed regional neck node metastases compared to only 25% cases had regional nodal recurrence where lymphovascular invasion was not present. This correlation was also significant with P = 0.0001. Therefore, in addition to the depth of invasion, perineural invasion and lymphovascular invasion are important prognostic indicators of occult regional neck node metastases in our study. No correlation between any other clinical or pathological parameter could be found that was significant. In their study on early SCC of oral tongue, An et al. concluded that T-stage, depth of invasion, intrinsic muscle involvement, and histological grade related to neck recurrence. While parameters such as age, gender, perineural invasion, lymphovascular emboli, resection margin, and pathologic nodal stage were not significantly related in their series.
The benefits of elective neck dissection in patients with oral cavity tumors with N0 neck are still not clear because the results of numerous existing studies on the topic have been generally inconclusive. Most studies have failed to show statistically significant differences in survival outcome between the patients with oral cavity cancers in elective neck treatment and observation groups.,,,, However, there have been few studies which showed a significant survival benefit in favor of elective neck dissection in oral carcinoma patients with clinically N0 neck.,,, Meta-analysis done by Fasunla et al. concluded that elective neck dissection significantly reduced the risk of death due to the disease. They also pointed to the fact that this observed pooled effect in their meta-analysis between elective neck dissection group, and observation might have been largely influenced by the older studies. Perhaps, if similar studies are conducted now that there are better investigative tools to detect and stage neck node metastasis, this observed difference might be absent. We strongly recommend elective conservative neck dissection in early SCC of the oral tongue with N0 status as 33% cases had a regional recurrence after surgical treatment of the primary cancer despite preoperative USG picking no abnormal nodes, in our study. Ideally, accurate preoperative assessment of the depth of infiltration can solve the problem to some extent, but inspection and palpation cannot reliably estimate tumor thickness. In addition, limitation of punch biopsy for the evaluation of tumor thickness has been reported. Shintani et al. have recently published their experience with intraoral USG and have shown a good correlation with the final histological sections. This may prove to be a useful tool for preoperative assessment of tumor thickness and decision making. If imaging studies (USG, CT, or MRI) are not available, measurement of tumor thickness obtained from a frozen section of the surgical specimen may be used. In our study, 5 years overall and DFS were 90% and 61%, respectively. An et al. reported 5-year OS rate of 97.1% in Stage I and 76.2% in Stage II SCC of the oral tongue. O-Charoenrat et al. reported 5 years actuarial OS, DSS, and DFS for the whole cohort of early tongue cancer patients of 65.7%, 67.8%, and 58.1%, respectively. Keski-Säntti et al. reported 3- and 5-year OS rates for the whole patient series of T1-2 N0 74% and 43% and the DSS rates were 82% and 79%, respectively. In our study, 91% cases could be salvaged after first nodal recurrence. An et al. also reported a high overall salvage rate of 70% after regional recurrence in their series on early stage oral tongue SCC. In comparison, other studies have reported a much lower salvage rate of about 30%–40% in case of regional recurrence in oral tongue cancers.,,, Our better salvage rate can be attributed to vigilant follow-up with clinical palpation and USG/guided FNA if indicated every 2 months for the 1st year. Limited follow-up time and an underpowered sample inherently limit our ability to draw more conclusions which are statistically significant. These limitations, however, highlight the benefit of single institution publishing their own clinical experience so that these data can eventually be consolidated and interpreted through meta-analysis.
| Conclusion|| |
Five years OS rate was comparable with the standard world literature because regional recurrence was successfully salvaged by modified neck dissection with or without postoperative radiotherapy. Despite high success rate of salvage treatment, recurrence of cancer is a fear to patients, and regular close follow-up is difficult for some patients. We recommend conservative elective neck dissection in T1-2 N0 SCC of the oral tongue, especially in cases with the depth of invasion more than 5 mm, presence of perineural and lymphovascular invasion. Clinical palpation and USG are inadequate for evaluation of the N0 neck. CT, MR, or PET can be utilized when available. The high salvage rate (91%) indicates that strict follow-up for the first 2 years aided with radiologic tools will help in early detection of recurrence in the primary site, as well as neck.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Yuen AP, Wei WI, Wong YM, Tang KC. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck 1997;19:583-8.
Haddadin KJ, Soutar DS, Oliver RJ, Webster MH, Robertson AG, MacDonald DG. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999;21:517-25.
Teichgraeber JF, Clairmont AA. The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: Treatment rationale. Head Neck Surg 1984;7:15-21.
Lim YC, Ahn JY, Koo BS, Lee JS, Chun JY, Park YM, et al
. Occult lymph node metastasis in early oral tongue squamous cell carcinoma. Korean J Otolaryngol Head Neck Surg 2006;49:407-10.
Yii NW, Patel SG, Rhys-Evans PH, Breach NM. Management of the N0 neck in early cancer of the oral tongue. Clin Otolaryngol Allied Sci 1999;24:75-9.
Keski-Säntti H, Atula T, Törnwall J, Koivunen P, Mäkitie A. Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol 2006;42:96-101.
Spiro RH, Strong EW. Surgical treatment of cancer of the tongue. Surg Clin North Am 1974;54:759-65.
Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, Freitas EQ, et al
. Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg 1994;168:391-4.
Kaya S, Yilmaz T, Gürsel B, Saraç S, Sennaroglu L. The value of elective neck dissection in treatment of cancer of the tongue. Am J Otolaryngol 2001;22:59-64.
Kowalski LP, Magrin J, Saboia M, Santos JC, Torloni H. Squamous cell carcinoma of the tongue: A review of 629 patients treated at a single institution. South Am J Cancer 1997;1:245-54.
Okamoto M, Nishimine M, Kishi M, Kirita T, Sugimura M, Nakamura M, et al
. Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue. J Oral Pathol Med 2002;31:227-33.
Brugère JM, Mosseri VF, Mamelle G, David JM, Buisset E, Vallicioni J, et al
. Nodal failures in patients with NO N+oral squamous cell carcinoma without capsular rupture. Head Neck 1996;18:133-7.
Khafif RA, Gelbfish GA, Tepper P, Attie JN. Elective radical neck dissection in epidermoid cancer of the head and neck. A retrospective analysis of 853 cases of mouth, pharynx, and larynx cancer. Cancer 1991;67:67-71.
Manni JJ, van den Hoogen FJ. Supraomohyoid neck dissection with frozen section biopsy as a staging procedure in the clinically node-negative neck in carcinoma of the oral cavity. Am J Surg 1991;162:373-6.
Moreau P, Goffart Y, Collignon J. Computed tomography of metastatic cervical lymph nodes. A clinical, computed tomographic, pathologic correlative study. Arch Otolaryngol Head Neck Surg 1990;116:1190-3.
Schuller DE, Bier-Laning CM, Sharma PK, Siegle RJ, Pellegrini AE, Karanfilov B, et al
. Tissue-conserving surgery for prognosis, treatment, and function preservation. Laryngoscope 1998;108(11 Pt 1):1599-604.
Don DM, Anzai Y, Lufkin RB, Fu YS, Calcaterra TC. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Laryngoscope 1995;105(7 Pt 1):669-74.
Akoglu E, Dutipek M, Bekis R, Degirmenci B, Ada E, Güneri A. Assessment of cervical lymph node metastasis with different imaging methods in patients with head and neck squamous cell carcinoma. J Otolaryngol 2005;34:384-94.
Haberal I, Celik H, Göçmen H, Akmansu H, Yörük M, Ozeri C. Which is important in the evaluation of metastatic lymph nodes in head and neck cancer: Palpation, ultrasonography, or computed tomography? Otolaryngol Head Neck Surg 2004;130:197-201.
Krestan C, Herneth AM, Formanek M, Czerny C. Modern imaging lymph node staging of the head and neck region. Eur J Radiol 2006;58:360-6.
Yamazaki Y, Saitoh M, Notani K, Tei K, Totsuka Y, Takinami S, et al
. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med 2008;22:177-84.
Yoon DY, Hwang HS, Chang SK, Rho YS, Ahn HY, Kim JH, et al
. CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol 2009;19:634-42.
Friedlander PL, Schantz SP, Shaha AR, Yu G, Shah JP. Squamous cell carcinoma of the tongue in young patients: A matched-pair analysis. Head Neck 1998;20:363-8.
Davidson BJ, Root WA, Trock BJ. Age and survival from squamous cell carcinoma of the oral tongue. Head Neck 2001;23:273-9.
Pitman KT, Johnson JT, Wagner RL, Myers EN. Cancer of the tongue in patients less than forty. Head Neck 2000;22:297-302.
Lim YC, Choi EC. Unilateral, clinically T2N0, squamous cell carcinoma of the tongue: Surgical outcome analysis. Int J Oral Maxillofac Surg 2007;36:610-4.
Fukano H, Matsuura H, Hasegawa Y, Nakamura S. Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck 1997;19:205-10.
O'Brien CJ, Lauer CS, Fredricks S, Clifford AR, McNeil EB, Bagia JS, et al
. Tumor thickness influences prognosis of T1 and T2 oral cavity cancer – But what thickness? Head Neck 2003;25:937-45.
Sparano A, Weinstein G, Chalian A, Yodul M, Weber R. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 2004;131:472-6.
An SY, Jung EJ, Lee M, Kwon TK, Sung MW, Jeon YK, et al
. Factors related to regional recurrence in early stage squamous cell carcinoma of the oral tongue. Clin Exp Otorhinolaryngol 2008;1:166-70.
Duvvuri U, Simental AA Jr., D'Angelo G, Johnson JT, Ferris RL, Gooding W, et al
. Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope 2004;114:2228-34.
Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg 1989;158:309-13.
Vandenbrouck C, Sancho-Garnier H, Chassagne D, Saravane D, Cachin Y, Micheau C. Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity: Results of a randomized clinical trial. Cancer 1980;46:386-90.
Yuen AP, Ho CM, Chow TL, Tang LC, Cheung WY, Ng RW, et al
. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck 2009;31:765-72.
Dias FL, Kligerman J, Matos de Sá G, Arcuri RA, Freitas EQ, Farias T, et al
. Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 2001;125:23-9.
Fasunla AJ, Greene BH, Timmesfeld N, Wiegand S, Werner JA, Sesterhenn AM. A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol 2011;47:320-4.
de Visscher JG, Schaapveld M, Grond AJ, van der Waal I. Relationship of tumor thickness in punch biopsy and subsequent surgical specimens in stage I squamous cell carcinoma of the lower lip. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:141-4.
Shintani S, Yoshihama Y, Ueyama Y, Terakado N, Kamei S, Fijimoto Y, et al
. The usefulness of intraoral ultrasonography in the evaluation of oral cancer. Int J Oral Maxillofac Surg 2001;30:139-43.
O-charoenrat P, Pillai G, Patel S, Fisher C, Archer D, Eccles S, et al
. Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer. Oral Oncol 2003;39:386-90.
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3], [Table 4]
|This article has been cited by|
||Lymphovascular invasion as a prognostic tool for oral squamous cell carcinoma: a comprehensive review
| ||M. Mascitti,L. Togni,V.C.A. Caponio,K. Zhurakivska,M.E. Bizzoca,M. Contaldo,R. Serpico,L. Lo Muzio,A. Santarelli |
| ||International Journal of Oral and Maxillofacial Surgery. 2021; |
|[Pubmed] | [DOI]|
||Surgical treatment of early tongue squamous cell carcinoma and patient survival
| ||Lansheng Zhu,Yanling Wang,Rui Li,Aiqun Liu,Xiaoping Zhang,Chunran Zuo,Xiaoting Xu |
| ||Oncology Letters. 2019; |
|[Pubmed] | [DOI]|
||Squamous cell carcinoma of the tongue in patients older than 45 years
| ||Constantino Ledesma-Montes,Juan Carlos Hernández-Guerrero,Marco Antonio Durán-Padilla,Avissai Alcántara-Vázquez |
| ||Brazilian Oral Research. 2018; 32(0) |
|[Pubmed] | [DOI]|
||Small oral tongue cancers (=?4 cm in diameter) with clinically negative neck: from the 7th to the 8th edition of the American Joint Committee on Cancer
| ||Alhadi Almangush,Antti A. Mäkitie,Laura K. Mäkinen,Joonas H. Kauppila,Matti Pukkila,Jaana Hagström,Jussi Laranne,Ylermi Soini,Luiz Paulo Kowalski,Reidar Grénman,Caj Haglund,Ricardo D. Coletta,Tuula Salo,Ilmo Leivo |
| ||Virchows Archiv. 2018; |
|[Pubmed] | [DOI]|
||Genomic analysis to assess disease progression and recurrence in patients with oral squamous cell carcinoma: – a preliminary study
| ||A. Kanatas,P. Chengot,T.K. Ong,M.W. Ho,N. Sethi,M. Taylor,A. Glover,H.M. Wood |
| ||British Journal of Oral and Maxillofacial Surgery. 2018; |
|[Pubmed] | [DOI]|